In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.
The study, led by TSRI Associate Professor Susana Valente, was published online Oct. 17 before print in the journal Cell Reports.
“No other anti-retroviral used in the clinic today is able to completely suppress viral production in infected cells in vivo,” Valente said. “When combining this drug with the standard cocktail of anti-retrovirals used to suppress infection in humanized mouse models of HIV-1 infection, our study found a drastic reduction in virus RNA present—it is really the proof-of-concept for a ‘functional cure.’”
Valente, a pioneer in this new approach, calls it “Block-and-Lock”—the approach blocks reactivation of the virus in cells, even during treatment interruptions, and locks HIV into durable state of latency.
Valente and her colleagues use a derivative of a natural compound called didehydro-Cortistatin A (dCA), which blocks replication in HIV-infected cells by inhibiting the viral transcriptional activator, called Tat, halting viral production, reactivation and replenishment of the latent viral reservoir.
“Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation,” Valente said. “It’s important to note that our study uses the maximum tolerable dose of the drug—with virtually no side effects.”
The scientists studied the combination therapy in a mouse model of HIV latency and persistence. Once the combined treatment regimen was halted, viral rebound was delayed up to 19 days, compared with just seven days in mouse models receiving only anti-retroviral treatment.
“This demonstrates the potential of ‘block-and-lock’ strategies,” said TSRI Research Associate Cari F. Kessing, co-first author of the study. “This study shows that a ‘functional cure’ approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption.”
“In half of the dCA treated mice, the virus was undetectable for 16 days after all treatment was halted,” said the University of North Carolina’s Christopher Nixon, another first author.
“We blocked Tat, and the cell’s machinery did the rest,” said TSRI Research Associate Chuan Li, a coauthor of the study. “The result was that the HIV promoter becomes repressed.”
Valente pointed out that the animal models were exposed to just a single month of treatment. “That’s a relatively short period of time,” she said. “We think longer treatments will result in longer, or even permanent, rebound delays. The question is how long? We’re studying that now.”
Because any viral rebound of HIV comes with a host of adverse effects, Valente noted, blocking that rebound would automatically reduce those effects.
“This is the only class of drugs that stops infected cells from making viruses outright,” said Valente. “All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production.”
The Latest on: HIV
Sattur woman who contracted HIV via blood transfer given government job
on June 16, 2019 at 11:43 pm
MADURAI: In a relief to the 23-year-old woman who contracted HIV after being transfused with contaminated blood, State Department of Health and Family Welfare provided her with a permanent government ... […]
Pakistan struggles with unprecedented HIV infections in children
on June 16, 2019 at 1:49 am
UN health teams are struggling to control an outbreak of HIV in southern Pakistan's Sindh province; most of those infected are children. Facing a lack of sufficient antiretroviral drugs, health ... […]
The Final Flourish? Life Ball’s Epic Last Stand for HIV/AIDS
on June 15, 2019 at 11:25 am
“You’ll need at least two,” says the optimistic volunteer, handing me a fistful of condoms as I enter Vienna’s City Hall for the 27th—and final—Life Ball, one of the world’s most famous HIV/AIDS ... […]
Preventing Type 1 Diabetes; Testing for HIV: It's PodMed Double T!
on June 15, 2019 at 11:03 am
PodMed Double T is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas Tech University Health ... […]
A cure for HIV? Gilead VP says one in development
on June 15, 2019 at 7:07 am
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being ... […]
Texas nurse with HIV accused of stealing narcotic, replacing vials at hospital with anesthetic
on June 15, 2019 at 7:03 am
A Texas nurse has been arrested on charges that he stole vials of a powerful narcotic to get high on the job and replaced them with the anesthetic lidocaine. The arrest report says Kyle Evans, 29, ... […]
Sonko says he has never contracted HIV in defamation suit against Star newspaper
on June 15, 2019 at 2:30 am
According to the court documents: Radio Africa published the said article as a vehicle for character assassination without any regard to his rights Governor Sonko also accused the writer of the ... […]
S.A. nurse with HIV allegedly stole drugs, got high on job, then refilled vials with mystery liquid
on June 14, 2019 at 11:02 pm
Kyle Evans, 29, is charged with tampering with a consumer product and drug diversion. Kyle Evans, 29, is charged with tampering with a consumer product and drug diversion. Caption Close Kyle Evans, 29 ... […]
CDC Director applauds Montgomery HIV/AIDS clinic
on June 14, 2019 at 7:55 pm
MONTGOMERY, Ala. (AP) — The director of the Centers for Disease Control says he's impressed by a Montgomery-based HIV/AIDS clinic and its commitment to providing health services to rural communities. ... […]
CDC director praises Alabama HIV clinic ahead of campaign
on June 14, 2019 at 4:07 pm
As the federal government prepares to launch an ambitious initiative to end the HIV epidemic, the director of the Centers for Disease Control on Friday applauded an Alabama HIV clinic's commitment ... […]
via Google News and Bing News